Metastatic cells form in a primary tumor and then break away from it, migrate to other organs, attach to them and form new tumors. This spread reduces patients’ chances of recovery. Scientists have discovered some of the mechanisms by which these cells arise. This is due to cells that have narrowly escaped cell death (apoptosis) following a chemotherapeutic treatment. Those cells reprogram themselves to acquire metastatic skills. Thanks to this study, these cells - called PAME by the researchers - now appear as new therapeutic targets. These results are published in the journal Cell Reports.
Metastatic cells occur in many forms of cancer. They originate in primary tumors and then break away and migrate. They travel through the tissues surrounding them, through blood vessels or lymphatic channels. Along the way, they may attach to one or more organs - such as the lungs, brain, bones or liver - and form new tumors also called metastases. This spread of the disease can negatively affect a patient’s chances of recovery.
Previous studies have identified metastatic cells during migration. It is also known that certain treatments can induce them. However, the precise mechanisms of their development remain a mystery. “We don’t know why, at a given moment, certain cells separate from the primary tumor,” explains the senior author. “The phenomenon is difficult to analyze because, before they migrate, there is nothing to distinguish future metastatic cells, or pro-metastatic cells, from other cells within the tumor”.
The team has discovered that the experience of imminent death within the primary tumor pushes certain cells to acquire pro-metastatic states. This near-death experience occurs in particular in the context of certain treatments aimed at depriving cancer cells of energy or oxygen. The team observed that these cells, which should have died, reprogram themselves and then present a high metastatic risk. These cells are called PAME for “post-apoptotic pro-metastatic cells”.
To reach these conclusions, the team used tumor samples taken from two colon cancer patients. Tumor cells from these samples were then transplanted into mice, where they grew and formed new tumors. These cells were subjected to an imminent death experience causing endoplasmic reticulum stress similar to that caused by certain chemotherapeutic drugs. This allowed the development of PAME cells.
The scientists also discovered that PAMEs trigger a storm of cytokines - proteins and other factors that ensure cell-to-cell communication - inducing adjacent cells to become PIMs, for PAME-induced migratory cells. These PIMs then associate with PAMEs and help them migrate to form metastases.
The present results open up promising new prospects for therapeutic management, including the prevention of the development of pro-metastatic fields generated by certain treatments. “Currently, one of the main criteria when defining a treatment is tumor shrinkage. Thanks to our study, PAME cells now appear as potential therapeutic and metastasis prevention targets to be taken into account”, concludes the senior author.
https://www.cell.com/cell-reports/fulltext/S2211-1247(22)00223-6
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fon-the-origin-of&filter=22
The origins of metastasis
- 1,215 views
- Added
Latest News
Novel epigenic editor, CHAR…
By newseditor
Posted 30 Jun
Multiomics identifies ALS s…
By newseditor
Posted 28 Jun
Reducing age-related inflam…
By newseditor
Posted 28 Jun
Alzheimer's disease symptom…
By newseditor
Posted 27 Jun
Gene-regulatory networks in…
By newseditor
Posted 27 Jun
Other Top Stories
Astrocytes play a key role in sleep
Read more
160 genes linked to brain shrinkage in study of 45,000 adults
Read more
Improved health in time-restricted feeding without altering the bod…
Read more
Neural transmission is more or less exclusive depending on the situ…
Read more
Repeated pregnancy loss may be tied to the olfactory system
Read more
Protocols
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
Publications
Antibody-activation of conn…
By newseditor
Posted 30 Jun
Mechanism of chaperone coor…
By newseditor
Posted 29 Jun
TMC7 functions as a suppres…
By newseditor
Posted 29 Jun
Multiomic ALS signatures hi…
By newseditor
Posted 28 Jun
What Is Thyroid Cancer?
By newseditor
Posted 28 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar